Littleton, CO (PRWEB) December 04, 2014 — CereScan, a national leader in functional brain diagnostics and molecular imaging, was selected as an Innovation Partner and invited to present at the Cavendish Global Health Impact Forums that took place November 10-13th at Oxford University in the UK and will take place April 27- 30, 2015 in San Diego. The Health Impact Forums help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within the health and life sciences. To accomplish this mission, the Forums showcase presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. Michael Moffat, Cavendish co-founder and President explains, “With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. CereScan’s advanced technologies and pioneering research clearly qualified them as an Innovation Partner and we are delighted that they have joined the Cavendish family.”

“We are honored to be selected as an Innovation Partner and to present our leading-edge research at these unique events. It is further recognition of our innovative approaches in the brain health arena,” said Dr. Richard Fort, CereScan President & COO. “We welcome the opportunity to interact with many of the world’s leading scientific minds, thought-leaders and philanthropic families who are dedicated to the common cause of improving the health and lives of people around the world.”

At the November Health Impact Forum, CereScan presented preliminary results of a research program, the Invisible Brain Injury Project, aimed at assessing a novel treatment for traumatic brain injuries (TBIs). This research program, funded by the Tug McGraw Foundation, recruited veterans who served in the Middle East conflicts and suffered TBIs. The aim of this project is to identify effective treatments of TBI and accelerate their adoption in brain healthcare. Final results of the IBIP will be presented at the next Cavendish Health Impact Forum in April, 2015 in San Diego.